* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 16 cents per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 20 cents per share.
* Revenue rose 55.3% to $29.05 million from a year ago;
analysts
expected $26.03 million.
* Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 16 cents.
* The mean earnings estimate of analysts had fallen by
about 200%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had risen by 0.8% this
quarter and gained 2.3% so far this year.
* The company reported a quarterly loss of $9.04 million.
* Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $30.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 5 at 10:35 p.m. All
figures in US dollars unless otherwise stated